Effects of Plasmodium falciparum infection on the pharmacokinetics of quinine and its metabolites in pregnant and non-pregnant Sudanese women

European Journal of Clinical Pharmacology

Volumn 66, Issue 12, 2010, Pages 1229-1234

  Mirghani, Rajaa A ^a   Elagib, Ishraga ^b   Elghazali, Gehad ^b   Hellgren, Urban ^a,c   Gustafsson, Lars L ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF KHARTOUM   (Sudan)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Malaria; Metabolites; Pharmacokinetics; Pregnancy; Quinine

Indexed keywords

10,11 DIHYDROXYQUININE; 3 HYDROXYQUININE; ARTEMETHER; HYDROQUININE; QUININE; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HUMAN; MALARIA FALCIPARUM; MAXIMUM PLASMA CONCENTRATION; PLASMODIUM FALCIPARUM; PREGNANCY; PRIORITY JOURNAL; SINGLE DRUG DOSE; SUDAN; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADULT; ANTIMALARIALS; AREA UNDER CURVE; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALARIA, FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, PARASITIC; QUININE; SUDAN;

EID: 78649321191     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-010-0877-3     Document Type: Article

References (32)

1. CE Shulman EK Dorman 2003 Importance and prevention of malaria in pregnancy Trans R Soc Trop Med Hyg 97 30 35 10.1016/S0035-9203(03)90012-5 12886801 (Pubitemid 36880725)
2. NJ White 1996 The treatment of malaria N Engl J Med 335 800 806 1:STN:280:DyaK28zmtFeitw%3D%3D 10.1056/NEJM199609123351107 8703186 (Pubitemid 26296541)
3. RA Mirghani U Hellgren, et al. 2003 Metabolism and elimination of quinine in healthy volunteers Eur J Clin Pharmacol 59 423 427 1:CAS:528: DC%2BD3sXnt1Kitrk%3D 10.1007/s00228-003-0637-8 12920491 (Pubitemid 37214950)
4. NJ White S Looareesuwan DA Warrell MJ Warrell D Bunnag T Harinasuta 1982 Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria Am J Med 73 564 572 1:STN:280:DyaL3s%2FhvFOktQ%3D%3D 10.1016/0002-9343(82)90337-0 6751085 (Pubitemid 12003291)
5. S Pukrittayakamee S Looareesuwan D Keeratithakul TME Davis P Teja-Isavadharm B Nagachinta A Weber AL Smith D Kyle NJ White 1997 A study of the factors affecting the metabolic clearance of quinine in malaria Eur J Clin Pharmacol 52 487 493 1:CAS:528:DyaK2sXlvVekurs%3D 10.1007/s002280050323 9342585 (Pubitemid 27395649)
6. NJ White 1997 Assessment of the pharmacodynamic properties of antimalarial drugs in vivo Antimicrob Agents Chemother 41 1413 1422 1:CAS:528:DyaK2sXktlyrtb4%3D 9210658
7. S Looareesuwan RE Phillips, et al. 1985 Quinine and severe falciparum malaria in late pregnancy Lancet 2 4 8 1:STN:280:DyaL2M3jvFCqsQ%3D%3D 10.1016/S0140-6736(85)90056-X 2861481
8. S Looareesuwan NJ White, et al. 1987 Quinine and severe falciparum malaria in late pregnancy Acta Leiden 55 115 120 1:STN:280:DyaL1c7gt1Ciuw%3D%3D 3321826
9. R McGready T Cho, et al. 1998 Quinine and mefloquine in the treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy Ann Trop Med Parasitol 92 643 653 1:CAS:528:DyaK1cXmvFamtb0%3D 10.1080/00034989859104 9924543 (Pubitemid 29354042)
10. PA Phillips-Howard D Wood 1996 The safety of antimalarial drugs in pregnancy Drug Saf 14 131 145 1:CAS:528:DyaK28XitlaqtbY%3D 10.2165/00002018- 199614030-00001 8934576
11. R McGready EA Ashley E Moo T Cho M Barends R Hutagalung, et al. 2005 A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy J Infect Dis 192 846 853 1:CAS:528:DC%2BD2MXhtVentrfI 10.1086/432551 16088834 (Pubitemid 41193082)
12. RA Mirghani O Ericsson, et al. 2001 Simultaneous determination of quinine and four metabolites in plasma and urine by high-performance liquid chromatography J Chromatogr B Biomed Sci Appl 754 57 64 1:CAS:528: DC%2BD3MXit1WntLs%3D 10.1016/S0378-4347(00)00577-6 11318427 (Pubitemid 32241068)
13. World Health Organization 2000 Severe falciparum malaria Trans R Soc Trop Med Hyg 94 suppl 1 S1 S90 10.1016/S0035-9203(00)90300-6
14. RA Mirghani U Hellgren PA Westerberg O Ericsson L Bertilsson LL Gustafsson 1999 The roles of cytochrome P450 3A4 and 1A2 in the 3-hydroxylation of quinine in vivo Clin Pharmacol Ther 66 454 460 1:CAS:528:DyaK1MXotVCjt74%3D 10.1016/S0009-9236(99)70008-1 10579472
15. S Wanwimolruk W Kang PF Coville S Viriyayudhakorn S Thitiarchakul 1995 Marked enhancement by rifampicin and lack of effect of isoniazid on the elimination of quinine in man Br J Clin Pharmacol 40 87 91 1:CAS:528: DyaK2MXnsVehuro%3D 8527275
16. S Pukrittayakamee P Pitisuttithum H Zhang A Jantra S Wanwimolruk NJ White 2002 Effects of cigarette smoking on quinine pharmacokinetics in malaria Eur J Clin Pharmacol 58 5 315 319 1:CAS:528:DC%2BD38XlvFSrsbo%3D 10.1007/s00228-002- 0447-4 12185554 (Pubitemid 34983921)
17. CP Babalola OO Bolaji FA Ogunbona A Sowunmi O Walker 1998 Pharmacokinetics of quinine in African patients with acute falciparum malaria Pharm World Sci 20 3 118 122 1:CAS:528:DyaK1cXktVSrs78%3D 10.1023/A: 1008699022244 9618735 (Pubitemid 28204306)
18. MA Hladunewich RA Lafayette, et al. 2004 The dynamics of glomerular filtration in the puerperium Am J Physiol Renal Physiol 286 496 503 10.1152/ajprenal.00194.2003
19. B Xu J Pekkanen, et al. 2003 Maternal sex hormones in early pregnancy and asthma among offspring: a case-control study J Allergy Clin Immunol 112 1101 1104 1:CAS:528:DC%2BD2cXhtlGgsLY%3D 10.1016/j.jaci.2003.09.027 14657866 (Pubitemid 37550001)
20. K Laine G Tybring, et al. 2000 No sex-related differences but significant inhibition by oral contraceptives of CYP2C19 activity as measured by the probe drugs mephenytoin and omeprazole in healthy Swedish white subjects Clin Pharmacol Ther 68 151 159 1:CAS:528:DC%2BD3cXmsFamu7Y%3D 10.1067/mcp.2000.108949 10976546 (Pubitemid 30659170)
21. K Laine U Yasar, et al. 2003 A screening study on the liability of eight different female sex steroids to inhibit CYP2C9, 2C19 and 3A4 activities in human liver microsomes Pharmacol Toxicol 93 77 81 1:CAS:528:DC%2BD3sXms1Wht7Y%3D 10.1034/j.1600-0773.2003.t01-1-930202-93-2.x 12899669
22. S Palovaara O Pelkonen, et al. 2003 Inhibition of cytochrome P450 2B6 activity by hormone replacement therapy and oral contraceptive as measured by bupropion hydroxylation Clin Pharmacol Ther 74 326 333 1:CAS:528: DC%2BD3sXnvVyksrs%3D 10.1016/S0009-9236(03)00202-9 14534519 (Pubitemid 37222853)
23. S Palovaara G Tybring, et al. 2003 The effect of ethinyloestradiol and levonorgestrel on the CYP2C19-mediated metabolism of omeprazole in healthy female subjects Br J Clin Pharmacol 56 232 237 1:CAS:528:DC%2BD3sXnsVeku7k%3D 10.1046/j.1365-2125.2003.01868.x 12895199 (Pubitemid 36981441)
24. R Loebstein A Lalkin, et al. 1997 Pharmacokinetic changes during pregnancy and their clinical relevance Clin Pharmacokinet 33 328 343 1:CAS:528:DyaK2sXnsFyku74%3D 10.2165/00003088-199733050-00002 9391746
25. T Shimada H Yamazaki, et al. 1994 Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians J Pharmacol Exp Ther 270 414 423 1:CAS:528:DyaK2cXlt1OmtL4%3D 8035341
26. SJ Kovacs DE Martin, et al. 1998 Urinary excretion of 6 beta-hydroxycortisol as an in vivo marker for CYP3A induction: applications and recommendations Clin Pharmacol Ther 63 617 622 1:CAS:528:DyaK1cXks12gsL0%3D 10.1016/S0009-9236(98)90084-4 9663175 (Pubitemid 28327888)
27. S Totsuka T Watanabe, et al. 1999 Increase in urinary excretion of 6beta-hydroxycortisol in common marmosets as a marker of hepatic CYP3A induction Arch Toxicol 73 4-5 203 207 1:CAS:528:DyaK1MXkt1Omtbc%3D 10.1007/s002040050607 10463384 (Pubitemid 29356682)
28. SL Eeckhoudt JP Desager, et al. 2001 Midazolam and cortisol metabolism before and after CYP3A induction in humans Int J Clin Pharmacol Ther 39 293 299 1:CAS:528:DC%2BD38XlsVanuw%3D%3D 11471773
29. MM Galteau F Shamsa 2003 Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals Eur J Clin Pharmacol 59 713 733 1:CAS:528: DC%2BD3sXpslOit74%3D 10.1007/s00228-003-0690-3 14605790 (Pubitemid 38041296)
30. C Ohkita M Goto 1990 Increased 6-hydroxycortisol excretion in pregnant women: implication of drug-metabolizing enzyme induction DICP 24 814-416
31. K Silamut NJ White, et al. 1985 Binding of quinine to plasma proteins in falciparum malaria Am J Trop Med Hyg 34 681 686 1:STN:280:DyaL2M3ns12itQ%3D%3D 3896000
32. S Wanwimolruk JR Denton 1992 Plasma protein binding of quinine: binding to human serum albumin, alpha 1-acid glycoprotein and plasma from patients with malaria J Pharm Pharmacol 44 806 811 1:CAS:528:DyaK3sXntlSnsg%3D%3D 1360505